In this regard Alisi et al. found that FGF21 levels increased progressively with the increase of hepatic steatosis, but when hepatic fat content reached the fourth quartile, FGF21 levels tended to decline (Alisi et al., 2013). The gene discussed is FGF21; the disease is Hepatic steatosis.